Related Experiment Video
Updated: Jan 6, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Development and validation of an artificial intelligence-based model for cardiovascular disease prediction using
Maryam Mahdavi1, Anoshirvan Kazemnejad2, Abbas Asosheh3
1Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Deep learning models accurately predict cardiovascular disease (CVD) events using longitudinal data. The Gated Recurrent Unit (GRU) model demonstrated strong performance, even with limited clinical variables, offering a promising tool for CVD risk assessment.
Area of Science:
- Machine learning applications in healthcare
- Cardiovascular disease epidemiology
- Predictive modeling in medicine
Background:
- Cardiovascular disease (CVD) poses a significant mortality challenge in Iran.
- Machine learning (ML) models are being explored to identify CVD risk factors.
- Evaluating deep learning and mixed-effects models for predicting 10-year CVD incidence.
Purpose of the Study:
- To determine significant predictive factors for cardiovascular disease (CVD) events in Iran.
- To assess the effectiveness of deep learning models (LSTM, GRU) and mixed-effects logistic models.
- To predict 10-year CVD incidence using longitudinal data.
Main Methods:
- Analysis of 4,872 adults (≥30 years) without prior CVD, followed for 10 years.
- Utilized demographic, behavioral, and biochemical data as input features.
- Employed Long Short-Term Memory (LSTM) and Gated Recurrent Unit (GRU) deep learning models to analyze risk factor dynamics.
Main Results:
- 545 participants (11.2%) experienced CVD events during follow-up.
- The GRU model outperformed the LSTM model in both sexes (AUC ~0.738-0.739).
- GRU model performance was comparable or superior to mixed-effects models, using only 21 variables.
Conclusions:
- Deep learning models, particularly GRU, effectively predict future cardiovascular disease events.
- These models leverage longitudinal medical data efficiently.
- Comparable performance achieved with a limited feature set highlights model efficacy.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
05:51Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health
Published on: February 21, 2025
Related Concept Videos
Longitudinal Studies
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...